Raiders fan with life-threatening heart issues named honorary captain A boy battling heart problems got the chance to live a dream on Sunday, acting as the honorary captain of the Oakland Raiders.
8-year-old to walk in fashion show after cancer battle An 8-year-old recently declared cancer-free will walk in an upcoming fashion show on Saturday to benefit the National Pediatric Cancer Foundation.
Internal watchdog told Medicare, Medicaid centers EpiPen was misclassified in 2009 The internal watchdog at the U.S. Department of Health and Human Services warned the office tasked with administering federal health insurance programs that Mylan NV's EpiPen was improperly classified as a generic drug in 2009, Senator Charles Grassley said Tuesday.
Frequent vaping by teens linked to heavy smoking later Adolescents with a regular vaping habit aren't just more likely to take up smoking; they also have higher odds of developing a heavy cigarette habit, a U.S. study suggests.
Second opinions not likely to change prostate cancer treatment Though many men diagnosed with prostate cancer seek a second opinion before beginning treatment, second opinions are unlikely to change their treatment decisions, according to a U.S. study.
Some babies may need allergy tests before trying peanuts Most of the time, parents can safely feed peanuts to babies on their own, but infants with a history of allergies should still get a checkup first, a research review confirms.
PTSD can persist for years in kids, but parents may not see it After a car crash, children can experience post-traumatic stress disorder for months or years afterward although parents may have trouble recognizing it, according to a new U.K. study.
Walgreens sues Theranos for breach of contract, seeks $140 million Walgreens Boots Alliance Inc sued Theranos Inc on Tuesday, seeking $140 million in damages while accusing its onetime lab-testing partner of breaching a contract, according to court records.
California drug pricing initiative headed for defeat A California ballot initiative aimed at reining in rising prices for prescription drugs was headed for defeat on Tuesday after pharmaceutical companies spent more than $100 million to fight it.
